Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus helveticus Rosell-52

What does the research say about Lactobacillus helveticus Rosell-52?

3 health outcomes synthesised

Lactobacillus helveticus Rosell-52 has been studied across three health outcomes: depression symptoms, cognitive function, and overall mental health. The strongest evidence is for reducing depression symptoms, supported by four studies showing moderate effects. No consistent effective dose or optimal population has emerged from the research, and most studies involved general adult populations.

Strongest evidence The most robust research on Lactobacillus helveticus Rosell-52 focuses on Reduced Depression Symptoms, where all four studies (four of four) reported beneficial effects with a moderate effect size. A 2025 meta-analysis of 7 RCTs found a significant moderate reduction in depressive symptoms (SMD -0.55; 95% CI -1.04 to -0.06). Evidence strength is rated as moderate, but the evidence base is small and subject to publication bias.

Mixed or weaker evidence For Improved Cognitive Function, all three studies reported benefits, but effect sizes varied from large to small, and only one of three reached statistical significance. The significant finding came from a meta-analysis in adults with depression, but it showed high heterogeneity (I²=82%) and examined probiotics broadly. Evidence strength is moderate but conclusions are preliminary. For Improved Mental Health, three review-level studies all reported small beneficial effects, none statistically significant, leading to a low evidence strength rating.

Effective dose patterns No consistent effective dose can be derived from the available evidence. Doses and study durations were not consistently reported across the depression studies, and no dose or form data were available for cognitive or mental health outcomes.

Population insights The depression evidence predominantly targets general adult populations. The cognitive function evidence comes specifically from adults with depression, while the mental health reviews did not specify a particular population. No cross-cutting population patterns (e.g., elderly or deficient groups) have emerged.

Notable caveats

  • All three syntheses note a small evidence base (3–4 studies each), making conclusions preliminary.
  • Publication bias is a concern across all outcomes; null-result studies are less likely to be published.
  • For cognitive function, the only statistically significant meta-analysis had high heterogeneity and examined probiotics overall, limiting specificity to this strain.
  • The mental health evidence comes entirely from reviews, not original RCTs, weakening causal inference.
  • No specific dose, form, or standardized duration data were available for any outcome.

Frequently asked

  • What is Lactobacillus helveticus Rosell-52 good for according to research?
    Research has investigated it for three outcomes: reducing depression symptoms (moderate evidence, 4 studies), improving cognitive function (moderate evidence, 3 studies with mixed results), and improving overall mental health (low evidence, 3 studies). The strongest and most consistent evidence supports a beneficial effect on depression symptoms.
  • What dose of Lactobacillus helveticus Rosell-52 is typically used in studies?
    Doses were not consistently reported across studies. No standard effective dose has been identified from the available evidence for any of the outcomes studied.
  • Who benefits most from Lactobacillus helveticus Rosell-52?
    The depression evidence comes from studies in general adult populations. For cognitive function, the strongest evidence involves adults with depression. There is not enough data to identify specific subgroups that benefit more than others.
  • Are there caveats or limitations in the research on Lactobacillus helveticus Rosell-52?
    Yes, the evidence base is small (3–4 studies per outcome), so all conclusions are preliminary. Publication bias is a concern—null-result studies are less likely to be published. Additionally, doses and study durations are often unreported, and some analyses combine different probiotics, making it difficult to isolate effects of this specific strain.
  • Does Lactobacillus helveticus Rosell-52 help with depression?
    Four studies all reported beneficial effects on depression symptoms, with a moderate effect size confirmed by a meta-analysis (SMD -0.55). The evidence strength is moderate, but the small number of studies and potential publication bias mean the findings should be interpreted cautiously.
  • Does Lactobacillus helveticus Rosell-52 improve cognitive function?
    Three studies all reported benefits, but only one reached statistical significance—a meta-analysis in adults with depression that showed a large effect but had high heterogeneity and examined probiotics overall. The evidence is mixed and not specific to this strain alone.

Most-studied combinations with Lactobacillus helveticus Rosell-52

most supplement research is combination research
  • Epic Pro 25-Strain Probiotic

    By Swanson

    4.6 (243 reviews)
    In Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    Out
    iHerb
    $23.99
    In
    Vitacost
    $-
    Out
    Vitamin Shoppe
    $-
    Out
  • FLORASSIST Mood Improve

    By Life Extension

    4.6 (597 reviews)
    Out of Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    Out
    iHerb
    $23.25
    In
    Vitacost
    $23.25
    In
    Vitamin Shoppe
    $-
    Out
  • Happy Mind

    By Swanson

    4.4 (19 reviews)
    Out of Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    Out
    iHerb
    $19.99
    In
    Vitacost
    $-
    Out
    Vitamin Shoppe
    $-
    Out
Back to top